
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17399624
[patent_doc_number] => 20220041714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/375821
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375821 | Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof | Jul 13, 2021 | Abandoned |
Array
(
[id] => 17519226
[patent_doc_number] => 20220105074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATION
[patent_app_type] => utility
[patent_app_number] => 17/372080
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372080 | ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATION | Jul 8, 2021 | Pending |
Array
(
[id] => 17170358
[patent_doc_number] => 20210324028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => IL-15 Variants and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/356754
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356754 | IL-15 Variants and Uses Thereof | Jun 23, 2021 | Abandoned |
Array
(
[id] => 18737860
[patent_doc_number] => 20230346760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB
[patent_app_type] => utility
[patent_app_number] => 17/997889
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997889 | AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB | May 5, 2021 | Pending |
Array
(
[id] => 17215653
[patent_doc_number] => 20210348991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITIONS AND METHODS RELATING TO REVERSIBLY COMPRESSIBLE TISSUE-HYDROGEL HYBRIDS
[patent_app_type] => utility
[patent_app_number] => 17/308462
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308462 | COMPOSITIONS AND METHODS RELATING TO REVERSIBLY COMPRESSIBLE TISSUE-HYDROGEL HYBRIDS | May 4, 2021 | Pending |
Array
(
[id] => 18453248
[patent_doc_number] => 20230194528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR DETECTING THE PRESENCE OF CORONAVIRUS-SPECIFIC ANTIBODIES IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/996294
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996294 | METHODS FOR DETECTING THE PRESENCE OF CORONAVIRUS-SPECIFIC ANTIBODIES IN A SUBJECT | Apr 12, 2021 | Pending |
Array
(
[id] => 18333750
[patent_doc_number] => 20230125698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => APHERESIS COLUMN FOR TREATING RHEUMATOID ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/913416
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913416 | APHERESIS COLUMN FOR TREATING RHEUMATOID ARTHRITIS | Mar 24, 2021 | Pending |
Array
(
[id] => 17704620
[patent_doc_number] => 20220204626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/594768
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594768 | BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF | Mar 18, 2021 | Pending |
Array
(
[id] => 18299145
[patent_doc_number] => 20230108831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Scaffold-Free Nerve Conduit
[patent_app_type] => utility
[patent_app_number] => 17/909263
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909263 | Scaffold-Free Nerve Conduit | Mar 4, 2021 | Pending |
Array
(
[id] => 18284763
[patent_doc_number] => 20230100235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => ANTICANCER AGENT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/796814
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796814 | ANTICANCER AGENT COMPOSITION | Feb 3, 2021 | Pending |
Array
(
[id] => 16856112
[patent_doc_number] => 20210156857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Immunoassay Methods Utilizing Trapping Conjugate
[patent_app_type] => utility
[patent_app_number] => 17/165116
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165116 | Immunoassay Methods Utilizing Trapping Conjugate | Feb 1, 2021 | Abandoned |
Array
(
[id] => 17005437
[patent_doc_number] => 20210236598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHODS FOR ORGAN REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/165286
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165286 | METHODS FOR ORGAN REGENERATION | Feb 1, 2021 | Abandoned |
Array
(
[id] => 18299867
[patent_doc_number] => 20230109553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => CHIMERIC SCAVENGER RECEPTORS TARGETED TO PHOSPHORYLATED TAU (PTAU) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/904473
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -80
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904473 | CHIMERIC SCAVENGER RECEPTORS TARGETED TO PHOSPHORYLATED TAU (PTAU) AND USES THEREOF | Jan 14, 2021 | Pending |
Array
(
[id] => 18212015
[patent_doc_number] => 20230058279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => HERBICIDE COMPOSITIONS WITH AUXIN HERBICIDE MONOETHANOLAMINE SALTS WITH IMPROVED PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/792604
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792604 | HERBICIDE COMPOSITIONS WITH AUXIN HERBICIDE MONOETHANOLAMINE SALTS WITH IMPROVED PROPERTIES | Jan 13, 2021 | Pending |
Array
(
[id] => 16966027
[patent_doc_number] => 20210217526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => CANCER DIAGNOSIS USING OPTIMAL CLUSTERING WITH SUCCESSIVE DECONVOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/145385
[patent_app_country] => US
[patent_app_date] => 2021-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145385 | CANCER DIAGNOSIS USING OPTIMAL CLUSTERING WITH SUCCESSIVE DECONVOLUTION | Jan 9, 2021 | Abandoned |
Array
(
[id] => 18077237
[patent_doc_number] => 20220402849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHOD FOR PRODUCING ACRYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/758486
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758486 | METHOD FOR PRODUCING ACRYLIC ACID | Jan 4, 2021 | Pending |
Array
(
[id] => 16899054
[patent_doc_number] => 20210177970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Multifunctional Treatment And Diagnostic Compositions And Methods
[patent_app_type] => utility
[patent_app_number] => 17/130819
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/130819 | Multifunctional Treatment And Diagnostic Compositions And Methods | Dec 21, 2020 | Abandoned |
Array
(
[id] => 18183253
[patent_doc_number] => 20230043983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT
[patent_app_type] => utility
[patent_app_number] => 17/785003
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785003
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785003 | AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT | Dec 10, 2020 | Abandoned |
Array
(
[id] => 18286275
[patent_doc_number] => 20230101747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CYCLIC COMPOUNDS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/781559
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -232
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781559 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | Dec 2, 2020 | Pending |
Array
(
[id] => 18091202
[patent_doc_number] => 20220409543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS ON CARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/776368
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776368 | DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS ON CARRIERS | Nov 26, 2020 | Abandoned |